Early research (Phase 1)UnknownNCT06050460What this trial is testingSA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19Who this might be right forCOVID-19 Sinovac Life Sciences Co., Ltd. 40
Post-approval studies (Phase 4)Study completedNCT01106482What this trial is testingAn Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBEWho this might be right forTick Borne Encephalitis (TBE) Novartis Vaccines 126
Not applicableStudy completedNCT04483908What this trial is testingCOVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody ResponsesWho this might be right forCOVID-19 Infection University Hospital, Basel, Switzerland 477
Early research (Phase 1)Looking for participantsNCT04843852What this trial is testingTLR-9 Adjuvanted Vaccination for Chronic Hepatitis BWho this might be right forHepatitis BChronic Hepatitis B University of Maryland, Baltimore 10
Post-approval studies (Phase 4)Study completedNCT02898922What this trial is testingRobust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in ChinaWho this might be right forHepatitis B Vaccines Shandong Province Centers for Disease Control and Prevention 300
Early research (Phase 1)Study completedNCT00001096What this trial is testingA Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT01993706What this trial is testingStudy of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy AdultsWho this might be right forHIV InfectionMonoclonal Antibody, HumanHIV Antibodies+2 more National Institute of Allergy and Infectious Diseases (NIAID) 29
Not applicableStudy completedNCT04448717What this trial is testingCOVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School ChildrenWho this might be right forSARS-CoV 2COVID-19 University of Zurich 4,250
Not applicableStudy completedNCT04961385What this trial is testingImmunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose VialWho this might be right forCovid19VaccineImmunogenicity Bangkok Metropolitan Administration Medical College and Vajira Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00219986What this trial is testingPhase I/II, Open-Label Trial of Three Monoclonal AntibodiesWho this might be right forHIV Infections Rockefeller University 12
Not applicableStudy completedNCT00002286What this trial is testingRetrovir in the Treatment of Psoriasis in HIV-Positive PatientsWho this might be right forHIV InfectionsPsoriasis Glaxo Wellcome
Not applicableUnknownNCT04444310What this trial is testingAntibody Responses in Contacts of COVID-19 PatientsWho this might be right forCOVID-19 Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00000135What this trial is testingStudies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)Who this might be right forHIV InfectionsCytomegalovirus Retinitis Johns Hopkins Bloomberg School of Public Health 209
Not applicableStudy completedNCT04542980What this trial is testingQualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19Who this might be right forSARS-CoV 2 InfectionCovid19 Namida Lab 44
Testing effectiveness (Phase 2)Ended earlyNCT00127569What this trial is testingRituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on ChemotherapyWho this might be right forHIV InfectionsGiant Lymph Node Hyperplasia French National Agency for Research on AIDS and Viral Hepatitis 25
Not applicableStudy completedNCT04860323What this trial is testingAnalytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP StudyWho this might be right forHIV Infection HIV Vaccine Trials Network 13
Early research (Phase 1)Study completedNCT02658968What this trial is testingStudy of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)Who this might be right forRelapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma Nordic Nanovector 18
Early research (Phase 1)Study completedNCT04700163What this trial is testingRU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy VolunteersWho this might be right forCovid19 Rockefeller University 23
Early research (Phase 1)Study completedNCT05310487What this trial is testingPhase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult SubjectsWho this might be right forChronic Hepatitis B Yangshengtang Co., Ltd 20
Not applicableStudy completedNCT04540484What this trial is testingCOVID-19 IgG Formation in Physicians at ALGH and Their Household MembersWho this might be right forCovid19SARS-CoV InfectionCommunicable Disease Wake Forest University Health Sciences 507